Tags: US | MED | Hepatitis Vaccine

Panel Recommends Hepatitis B Vaccine

Panel Recommends Hepatitis B Vaccine
(Copyright DPC)

Wednesday, 21 February 2018 02:24 PM

A federal advisory panel on Wednesday recommended a new vaccine against hepatitis B.

The vaccine, called Heplisav-B, was licensed for use in the U.S. in November and is the first new hepatitis B vaccine in 25 years.

Hepatitis B vaccines have been in childhood shots for decades. The new vaccine made by Dynavax Technologies Corp. is for adults and is given in two shots over a month. It uses an additive that boosts the body's immune response.

The hepatitis B virus can damage the liver and is spread through contact with blood or other bodily fluids. Cases have been rising, a trend linked to the heroin and opioid epidemic. Meanwhile, researchers found older vaccines falter in diabetics and older adults.

The Advisory Committee on Immunization Practices endorsed the vaccine during a meeting in Atlanta. The government usually adopts its recommendations.

© Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Health-News
A federal advisory panel recommended a new vaccine against hepatitis B for adults.
US, MED, Hepatitis Vaccine
140
2018-24-21
Wednesday, 21 February 2018 02:24 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved